SCHEMBL24710948

SCHEMBL24710948

CCOc1ccc(C(=O)Nc2ccc(N3CCN(C(=O)c4cccs4)CC3)c(Cl)c2)cc1Br

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 14/20 0.61
▸ MEN1 O00255 6/20 0.61
▸ KMT2A Q03164 6/20 0.61
▸ HTT P42858 3/20 0.61
▸ MAPK1 P28482 2/20 0.61
▸ ALDH1A1 P00352 4/20 0.58
▸ GAA P10253 3/20 0.58
▸ SMN1; SMN2 Q16637 4/20 0.56
▸ HSD17B10 Q99714 3/20 0.56
▸ ALOX15 P16050 1/20 0.56
▸ ALOX12 P18054 1/20 0.56
▸ NR4A1 P22736 1/20 0.56
▸ LMNA P02545 3/20 0.54
▸ USP2 O75604 1/20 0.54
▸ TSHR P16473 1/20 0.54
▸ NPSR1 Q6W5P4 2/20 0.53
▸ KDM4E B2RXH2 1/20 0.53
▸ POLB P06746 1/20 0.53
▸ CYP3A4 P08684 1/20 0.53
▸ CYP2C9 P11712 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24711241 0.88 MAPT (0.72) MAPTMEN1KMT2AHTTALDH1A1
SCHEMBL24710964 0.79 MAPT (0.65) MAPTMEN1KMT2AHTTMAPK1
SCHEMBL24710952 0.78 MAPT (0.70) MAPTMEN1KMT2AHTTMAPK1
SCHEMBL24710828 0.76 MAPT (0.74) MAPTMEN1KMT2AHTTMAPK1
SCHEMBL13856442 0.72 MAPT (1.00) MAPTMEN1KMT2AHTTALDH1A1
SCHEMBL24711487 0.71 MAPT (0.56) MAPTMEN1KMT2AHTTMAPK1
SCHEMBL24711233 0.69 MAPT (0.70) MAPTKMT2AHTTALDH1A1GAA
SCHEMBL24711140 0.69 MAPT (0.63) MAPTMEN1KMT2AHTTALDH1A1
SCHEMBL6244283 0.68 MAPT (0.83) MAPTMEN1KMT2AHTTMAPK1
SCHEMBL10018556 0.67 KMT2A (0.74) MAPTMEN1KMT2AHTTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220395500-A1 SMALL MOLECULE ACTIVATORS OF INTERFERON REGULATORY FACTOR 3 AND METHODS OF USE THEREOF NEURALEXO, INC. 2022-12-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220395500-A1 SMALL MOLECULE ACTIVATORS OF INTERFERON REGULATORY FACTOR 3 AND METHODS OF USE THEREOF IRF3, IRF2BP2, STAT1 MAPT 4038/4885MEN1 4664/4885KMT2A 3862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback